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Abstract
The poly(ADP-ribose) polymerase (PARP) protein family generates ADP-ribose (ADPr)
modifications onto target proteins using NAD+ as substrate. Based on the composition of three
NAD+ coordinating amino acids, the H-Y-E motif, each PARP is predicted to generate either
poly(ADP-ribose) (PAR) or mono(ADP-ribose) (MAR). However, the reaction product of each
PARP has not been clearly defined, and is an important priority since PAR and MAR function via
distinct mechanisms. Here we show that the majority of PARPs generate MAR, not PAR, and
demonstrate that the H-Y-E motif is not the sole indicator of PARP activity. We identify
automodification sites on seven PARPs, and demonstrate that MAR and PAR generating PARPs
modify similar amino acids, suggesting that the sequence and structural constraints limiting
PARPs to MAR synthesis do not limit their ability to modify canonical amino acid targets. In
addition, we identify cysteine as a novel amino acid target for ADP-ribosylation on PARPs.
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Introduction
The primary function of the seventeen-member poly(ADP-ribose) polymerase (PARP)
protein family is to generate ADP-ribose (ADPr) modifications onto target proteins using
NAD+ as substrate1. The best understood PARP functions involve poly(ADP-ribose) (PAR)
synthesis and include physiological functions in cell division2-6, transcriptional regulation
(reviewed in 7) and regulation of protein degradation8,9. PAR also functions during cell
stress responses such as DNA damage10, heat shock11,12, and the cytoplasmic stress
response13. Recently it was shown that certain PARPs, such as PARP10 and PARP14, only
generate mono(ADP-ribose) (MAR)14. However it is not clear if other PARP family
members are also limited to MAR synthesis. Computational analysis of amino acid sequence
in combination with this data led to the prediction that each PARP can generate either PAR
or MAR, but not both14.
The functional distinction between PAR and MAR synthesis is important since the type of
ADPr modification generated has critical impacts on the potential mechanisms of function.
MAR modifications add single ADPr units on to proteins whereas PAR polymers can be up
to 200 units in length when generated in vitro, and can contain both linear and branched
glycosidic linkages15. Although both can regulate the function of target proteins via direct
covalent modification, PAR can also recruit binding proteins that contain a 20-amino acid
PAR binding motif16 as well as characterized PAR binding domains including Macro17,
PBZ18 and WWE19 domains. This allows PAR to function as a reversible high-density
protein binding scaffold for the nucleation of multiprotein complexes of great complexity.
Therefore, identifying the type of ADPr modifications generated by each PARP is critical to
understanding specific mechanisms of PARP function.
Although less is known about MAR, our recent family-wide analysis of PARP function and
previous work by other labs has identified important functions for PARPs predicted to
generate MAR. These include regulation of transcription (PARP3, 7 and 14)20-22, signal
transduction pathways (PARP10 and 14)23-25, the unfolded protein response (PARP16)26,
the actin cytoskeleton (PARP14)27, and membrane organelles (PARP8 and 16)27. The
diversity of pathways that appear to be regulated by MAR demonstrates the general
importance of MAR in cell function and suggests that a deeper understanding of the
molecule is in order.
The primary predictors of PARP enzymatic activity are thought to be the amino acids that
catalyze the ADP-ribose transfer reaction. The PARP catalytic domain contains a signature
H-Y-E motif originally identified in various bacterial mono-ADP-ribosyltransferase
(mART) toxins that also mediate ADP-ribose transfer. Histidine and tyrosine residues are
required for binding of the substrate NAD+ and the glutamate for catalysis28,29. Since most
PARPs contain an isoleucine, leucine or tyrosine in place of the catalytic glutamate they are
predicted to generate MAR14 (Supplementary Table 1). Additionally, PARP9 and 13 also
contain amino acid substitutions for the NAD+ binding histidine and are predicted to be
inactive14.
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Secondary structural features of the PARP catalytic domain are also predicted to influence
catalytic activity. In addition to the NAD+ binding residues of the H-Y-E motif, the Donor
loop (D-loop) shapes the substrate binding pocket and interacts with NAD+30. This loop
varies in size and rigidity within the PARP family and analysis of the binding of small
molecule PARP inhibitors to PARP catalytic domains identified the D-loop as a structural
element that contributes to differential inhibitor binding30. Therefore, the shape of the
substrate binding pocket, partly lined by the D-loop, could contribute to differences in
NAD+ binding among the PARPs and impact catalytic activity or enzyme kinetics. Another
structural component of the PARP catalytic domain is the acceptor pocket, partly lined by
the loop between β sheets 4 and 5 and referred to as the acceptor loop. This loop is
implicated in the binding of either protein substrate or ADPr acceptor for bacterial mARTs
or eukaryotic PARPs respectively and varies in length among PARP proteins14,31-33.
Therefore, the ability to bind to an incoming ADPr unit on a PAR polymer could vary based
on the structure of the acceptor loop, impacting the ability to elongate a PAR chain or create
a branched modification.
Whether or not these amino acid or structural constraints thought to limit PARP activity to
MAR synthesis affect selectivity of amino acid targets is unknown. Most current data
pertaining to amino acid selectivity is based on the PAR generating PARP1, however even
here amino acid selectivity is unclear. Although most studies identify glutamate and
aspartate residues as the primary targets of modification34-37, lysines have also been
identified38,39.
Here we take a systematic approach to examine PARP enzymatic activity, assaying
automodification of each member of the PARP family of proteins with high resolution. Our
results suggest that the primary enzymatic activity for the PARPs is MAR synthesis and that
the amino acid identity of the H-Y-E motif is not the sole indicator of PAR or MAR
synthesis. They further demonstrate that MAR and PAR generating PARPs modify both
acidic amino acids and lysines and identify ADPr modifications on cysteine residues of
PARPs. In conjunction with our recent work identifying new PARP functions from a PARP
family wide analysis, these results demonstrate the importance of MAR as a product of
PARP activity as the majority of PARP phenotypes result from knockdown of MAR
generating PARPs27.
Results
PARP Enzymatic Activity Assays
Recent work has provided experimental evidence demonstrating PAR or MAR activity for
several of the PARPs (Supplementary Table 1). The most commonly used approach has
been resolution of automodified PARPs on SDS-PAGE gels13,14,22,26,40-47. PARPs that
appear as distinct bands are identified as MARylating, and those that resolve as smears due
to heterogeneity of attached polymers are identified as PARylating (Supplementary Table
1). One problem with this approach is that it cannot distinguish between the addition of
single ADPr units or addition of short oligomers of ADPr since each ADPr unit adds only
0.6 kDa to a protein and protein resolution on SDS-PAGE is both mass and charge
dependent making resolution of small modifications unpredictable.
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To provide a more accurate analysis of PARP reaction products we expressed and purified
each full-length PARP as N-terminal GFP fusions in human 293F cells, then performed
standard automodification assays48 previously shown to effectively measure enzymatic
activity since the majority of PARP activity is self-directed49. Three approaches were used
to analyze the reaction products: standard PAGE based automodification assays (Fig. 1),
hydrolysis with enzymes specific for PAR or MAR and chemical treatments to release ADPr
modifications at the site of protein linkage (Fig. 2, 3). The released products generated by
approach 2 and 3 were then analyzed using high resolution TBE-acrylamide sequencing gels
or thin layer chromatography (TLC) (Fig. 2, 3).
Most PARPs do not synthesize PAR upon automodification
Incorporation reactions were performed on protein A magnetic beads using anti-GFP
precipitation of the GFP-PARP fusions. Bead-bound GFP-PARPs were incubated with 5 or
10 μM NAD+ supplemented with a constant ratio of 32P-NAD+ (Fig. 1). Total NAD+
concentrations were kept low to increase the ratio of hot:cold NAD+ due to weak signal
incorporation by many PARPs relative to PARP1 as identified during initial analysis.
PARP1 exhibited robust polymer synthesis even at these low NAD+ concentrations,
indicating that NAD+ is not limiting in our reactions (Fig. 1).
Several controls were performed to confirm that assay conditions did not affect PARP
enzymatic activity. First we examined the effect of the N-terminal location of the GFP tag
on PARP enzymatic activity by comparing the activity of both N and C-terminal GFP
fusions to PARP1. Both incorporated similar amounts of 32P-ADPr, suggesting that the N-
terminal location of the tag does not affect PARP enzymatic activity, similar to published
results for PARP10 using the similarly sized N-terminal TAP tag (Supplementary Fig. 1a)14.
We examined the possibility that the presence of a tag itself affects PARP enzymatic activity
by comparing NAD+ incorporation of GFP-PARP10, SBP-PARP10 and untagged PARP10
(Supplementary Fig. 1b). These results show that the presence of the GFP fusion had no
appreciable affect on PARP activity. Finally bead bound GFP-PARP10 and soluble PARP10
exhibited similar enzymatic activity suggesting that performing the analysis on beads does
not affect PARP activity (Supplementary Fig. 1b).
Kleine et al. predicted PAR synthesis activity for H-Y-E containing PARPs. Consistent with
this prediction and previously reported results, PARP1, 2, 5a and 5b incorporated ADPr in a
manner consistent with PAR synthesis15,40,41,43 (Fig. 1). PARP1 and 2 automodification
reactions contained additional signal that did not resolve in the SDS-PAGE gel and instead
remained in the well, potentially due to branching, or very long polymer length (Fig. 1).
In contrast to predictions by Kleine et al., the H-Y-E containing PARP3 and 4 incorporated
ADPr in a pattern indicative of MAR synthesis, consistent with previously published reports
for full length PARP345 and bacterially expressed PARP4 catalytic domain42. PARP4 is a
component of the cytoplasmic Vault complex, and the ADP-ribosylation activity of purified
Vault complexes containing PARP4 suggest that it can generate PAR42. Thus PARP4 could
exhibit PAR synthesis activity when bound to Vault proteins, or the PAR activity found in
Vault complexes could be due to other co-purifying PARPs. Interestingly, the Coomassie
stain for GFP-PARP4 shows a single band at ~200kD, however additional lower molecular
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weight signal was identified on the autoradiogram. This signal is likely due to a C-terminal
cleavage product of GFP-PARP4 since the N-terminal GFP fusion is detectable at that
molecular weight via anti-GFP blot, whereas an antibody raised against the very C-terminus
of PARP4 does not detect the lower molecular weight band (Supplementary Fig. 2).
PARP6, 7, 8, 10, 11, 12, 14, 15 and 16 each incorporated ADPr in a manner consistent with
MAR synthesis (Fig. 1). Identification of MAR activity for PARP7, 10, 12, 14, 15 and 16 is
consistent with previously published reports13,14,22,26,47. Interestingly, PARP15 exhibited
weak automodification activity, instead strongly modifying a co-precipitating protein. This
result suggests that in contrast to other PARPs, PARP15 is not a major target of its own
enzymatic activity.
PARP9 failed to incorporate detectable amounts of ADPr, suggesting that it is catalytically
inactive, in agreement with previous reports (Fig. 1)44. Very weak NAD+ incorporation was
observed for both isoforms of PARP13, predicted to be inactive due to the presence of a Q-
Y-V catalytic motif for PARP13.1, and the lack of a catalytic domain for PARP13.214,50.
Previous reports on the activity of bacterially purified PARP13 catalytic domain did not
detect any NAD+ incorporation14 and our results are consistent with this (Supplementary
Fig. 3). Instead the weak incorporation identified in PARP13 purified from 293F cells could
be due to activity of a sub-stoichiometric co-purifying PARP.
The majority of PARPs are mono(ADP-ribosyl)ases
To further confirm ADP-ribosylation activity, in vitro automodified PARPs were treated
with enzymes specific for PAR or MAR hydrolysis or chemicals known to release ADPr
from proteins at the site of protein linkage. The signal that remained attached to the PARP
was then examined by resolving on SDS-PAGE followed by autoradiography, and the
released reaction products examined by thin layer chromatography (TLC) or high resolution
TBE-polyacrylamide sequencing gels capable of resolving single units of ADPr (Fig. 2, 3).
Each assay was performed a minimum of two times and the results were highly concordant.
PAR hydrolysis was analyzed using T. curvata poly(ADP-ribose) glycohydrolase (T.c.
PARG) treatment, which hydrolyzes PAR chains, releasing ADPr as a product48. There have
been conflicting reports on the ability of PARG to hydrolyze proximal ADPr-protein
linkages or MAR14,48,51. Under our reaction conditions we did not observe substantial
signal release from automodified PARP1E988Q, shown to generate only MAR modifications,
suggesting that T.c. PARG does not hydrolyze MAR to a significant extent, although a few
exceptions are described below (Supplementary Fig. 4a)29. MAR hydrolysis was analyzed
using MacroD1 and terminal (ADP-ribose) glycohydrolase (TARG1)36,52,53. Both enzymes
hydrolyze MAR, however whereas MacroD1 has no known activity on PAR51,53,54, TARG1
can release PAR chains through hydrolysis at the proximal ADPr-protein linkage, but cannot
hydrolyze released polymers to ADPr36.
We first verified that the hydrolysis activity of T.c. PARG, MacroD1 and TARG is not
affected by their substrate being bead bound by comparing hydrolysis of bead bound
automodified GFP-PARP10 or SBP-PARP10 to soluble PARP10 (Supplementary Fig. 4b).
There was no effect of bead binding on hydrolysis activity. To identify an appropriate
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enzyme concentration for the reactions, automodified GFP-PARP10 was treated with
increasing amounts of TARG1, MacroD1 and T.c. PARG ranging from 50nM to 500nM
(Supplementary Fig. 4c). We also directly compared TARG1 and MacroD1 hydrolysis
activity on automodified PARP1, 7, 10 and 14 (Supplementary Fig. 4d). Hydrolysis activity
of both enzymes was comparable and we chose MacroD1 for our subsequent analyses to
minimize the possibility of reactivity to PAR (Supplementary Fig. 4d). For all analyses,
treatment with the same concentrations catalytically inactive mutants of T.c. PARG, TARG
and MacroD1 did not result in significant hydrolysis of ADPr modifications and were used
as controls (Supplementary Fig. 4a-d).
Several chemicals have been identified that specifically cleave ADPr-protein linkages,
releasing intact ADPr modifications55. Three were tested: 2-
(cyclohexylamino)ethanesulfonic acid (CHES), pH9, Hydroxylamine, pH 7.5 and sodium
hydroxide, pH12 (Fig. 4). Although CHES and NaOH treatment showed similar amounts of
PAR release from in vitro automodified PARP1, NaOH resulted in degradation of free ADPr
to AMP, consistent with previous reports56. We were unable to obtain substantial release of
intact PAR upon neutral hydroxylamine treatment of PARP1, previously shown to result in
robust release of carboxylate ADPr linkages55 (Fig. 4). Therefore, CHES treatment was
utilized for subsequent assays due to its ability to release ADPr from both acidic and lysine
residues, allowing for the identification of ADPr modifications from both chemical
linkages55.
PARP1 and 2 contain DNA binding domains, and their enzymatic activity is highly
upregulated upon addition of DNA41,57. PARP3 does not contain a defined DNA binding
domain, however it was recently shown to bind and to be activated by DNA46,58. Our initial
analyses of PARP3 activity identified low enzymatic activity in the absence of DNA to a
point where the enzymatic activity of PARP3 was difficult to discern above background.
Therefore, we compared the activity of GFP-PARP1-3 in the absence or presence of DNA
(Fig. 5). Automodification activity of all three PARPs was highly increased in the presence
of DNA, consistent with previous results. In contrast, addition of DNA to PARP10
automodification reactions resulted in a slight decrease in activity (Fig. 5). Addition of DNA
to the PARP3 reactions did not change its reaction product-PARP3 still resolved as a distinct
band consistent with MAR synthesis, indicating that ADPr synthesis activity is not altered
upon upregulation of PARP enzymatic activity. Because addition of DNA to incorporation
reactions increases activity without altering the pattern of NAD+ incorporation, PARPs1-3
were automodified in the presence of DNA for TLC and sequencing gel analysis.
Results for H-Y-E PARPs are shown in Figure 2 and summarized in Table 1. CHES
treatment of the H-Y-E PARPs 1, 2, 5a and 5b resulted in release of PAR, seen as ladders on
high-resolution DNA sequencing gels (Fig. 2). T.c. PARG treatment hydrolyzed these PAR
chains, causing the SDS-PAGE signal for each to collapse to distinct bands at their
respective molecular weight, releasing ADPr as the major product as detected by TLC (Fig.
2; see Supplementary Fig. 4e for migration patterns of cold and hot standards on TLC).
Sequencing gel analysis of the released T.c. PARG product showed that some short ADPr
oligomers remained (Fig. 2), consistent with previous data demonstrating that T.c. PARG
has lower activity on short PAR chains59. Finally, although MacroD1 did not cause a similar
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collapse of automodification signal to distinct band, treatment resulted in some release of
PAR chains for PARPs 1, 2, 5a and 5b (Fig. 2). Treatment with MacroD1 and T.c. PARG
catalytic dead mutants had no effect on the ADPr modifications. In contrast, CHES,
MacroD1 and T.c. PARG treatment of H-Y-E PARPs 3 and 4 resulted in the release of
ADPr seen on both TLC and sequencing gel (Fig. 2), similar to what was observed for H-Y-
(I/L/Y) PARPs (below, Fig. 3). Since T.c PARG treatment resulted in minor ADPr release
for PARP3 and 4, we confirmed that they contain attached MAR by treating with increasing
amounts of bovine PARG using automodified PARP1 and PARP10 as controls (Fig. 6).
Bovine PARG treatment of PARP3, 4 and 10 had no effect on the ADPr signal attached to
the protein whereas a dose-dependent loss of ADPr signal was identified for PARP1.
Together these results identify MAR synthesis activity for PARPs 3 and 4 (Fig. 6).
Results for non H-Y-E PARPs are shown in Figure 3 and summarized in Table 1. H-Y-
(I/L/Y) PARPs exhibited release of ADPr as the major product of CHES and MacroD1
treatment (Fig. 3). Treatment with T.c PARG also resulted in release of ADPr for some of
these PARPs (albeit to a lesser extent than MacroD1 treatment), suggesting that some of the
mono(ADP-ribosyl)ated sites might be sterically accessible for cleavage with the bacterial
enzyme. (Fig. 3 and Supplementary Fig. 5). The minor signal present at 2 units of ADPr for
CHES treatment for many of the non-H-Y-E PARPs might be due to artifact as it was also
identified for PARP1E988Q, although it is possible that this mutant could also synthesize
short oligomers not previously detected (Supplementary Fig. 5). Additionally, increased
background signal was observed for PARP4 and 16, possibly due to low incorporation
activity under these conditions. Together these results suggest that the primary activity of
the H-Y-(I/L/Y) PARPs is mono(ADP-ribosyl)ation.
The Donor and Acceptor loops impact enzymatic activity.
Our results identifying PARP3 and 4 as MARylating enzymes suggested that the simple
presence of the H-Y-E motif is not sufficient to determine PAR synthesis- other structural
elements must also be important. Since it has been postulated that the D-loop is an important
structural component of the NAD+ binding pocket30, we examined the D-loops of the H-Y-E
PARPs. In addition we examined their acceptor loops since they are thought to bind to
elongating ADPr and protein targets and could therefore help determine the type of ADPr
modification generated31.
It is possible that the lack of PAR activity for PARP3 is due to the structure of its D-loop
since this loop is a major structural difference between the PARP3 and PARP1 and 2
catalytic domains. The PARP1 D-loop contains 3 proline residues to contribute to loop
rigidity whereas PARP3 only has one (Supplementary Fig. 6). Additionally, PARP3 lacks a
tyrosine residue present in PARP1 that interacts with substrate, potentially affecting its
ability to bind NAD+ (Supplementary Fig. 6)60,61. Together this suggests that structural
features of the D-loop can impact catalytic activity and that the presence of a H-Y-E is not
the sole indicator of PAR activity. The acceptor site is partially lined by the loop between β
sheets 4 and 5 of the PARP catalytic domain and is thought to be important for substrate
recognition14,31,32. Differences in amino acids lining the acceptor pocket are suggested to
effect the type of ADPr that can be generated61 and the acceptor loop length is specifically
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implicated in determining PARP catalytic activity14. Therefore we tested its impact on
enzymatic activity or the type of modification that can be generated.
We tested the importance of the D-loop and acceptor loop on PARP1 enzymatic activity by
assaying NAD+ incorporation activity of PARP1/PARP16 chimeras in which either the
donor or acceptor loops were swapped (Fig. 7a). The PARP16 D-loop was specifically
chosen since it lacks prolines and is presumed to be relatively flexible, is not homologous to
PARP1-3 D-loop sequence, and comes from a PARP with low MAR generating activity (see
discussion). PARP1P16 D-loop no longer generated PAR and instead exhibited MAR
synthesis activity, similar to what was previously shown for PARP1 catalytic glutamate
point mutants29, confirming the importance of the D-loop on enzymatic activity (Fig. 7a). In
contrast PARP1P16 A-loop synthesized polymer, although incorporation activity was greatly
reduced (Fig. 7a). This highlights the importance of the acceptor loop to PARP enzymatic
activity and is consistent with a function for the acceptor pocket in binding of the terminal
ADPr unit to be elongated by PARP1.
Replacement of the PARP16 donor or acceptor loops with those from PARP1 did not
change the MAR activity of PARP16, although PARP16P1 A-loop exhibited decreased
enzymatic activity (Fig. 7a). Replacement of the tyrosine from the catalytic residues with
glutamate completely abolished activity, similar to what was previously shown for
PARP1014. Interestingly, substituting either the donor or acceptor loop of PARP1 in
PARP16Y254E restores MAR synthesis activity, indicating the primary sequence of the
catalytic residues are not the sole determinant of enzymatic activity (Fig. 7a).
Because the D-loop appeared to have the greatest impact on enzymatic activity, altering the
nature of the modification generated by PARP1, we further investigated its contribution to
ADPr synthesis. To do so, we generated PARP1/PARP3 chimeras in which the donor loops
were swapped, and a PARP1 mutant in which the 3 proline residues of the D-loop (P881,
P882, P885) were mutated to alanines (PARP1D-loop Pro) (Fig. 7b, c). We first examined
enzymatic activity using fixed concentrations of 32PNAD+ (10 μM) in the presence and
absence of DNA. PARP1D-loop Pro still had PAR synthesis activity in both conditions,
although the pattern of incorporation differed from wild type PARP1. Higher molecular
weight product appeared to dominate the reaction product in PARP1D-loop Pro reactions
regardless of the reaction conditions (Fig. 7b, c and Supplementary Fig. 7a, see below). In
contrast, the PARP1P3 D-loop no longer generated PAR and instead exhibited MAR synthesis
activity consistent with results from the PARP1P16 D-loop chimera (Fig. 7a-c). Because of the
high level of PAR synthesis for wild type PARP1 and PARP1D-loop Pro in the presence of
DNA, the coomassie signal appears weaker due to smearing of the signal (Fig. 7b). In
contrast, since PARP1P3 D-loop resolves as a distinct band, the coomassie signal is much
stronger (Fig. 7b). Unlike the PARP16 chimera, the PARP3P1 D-loop was inactive. These
results suggest that simple replacement with a PAR competent D-loop is not sufficient for
PAR synthesis activity (Fig. 7a-c).
To determine if a similar pattern of PAR synthesis occurs for PARP1D-loop Pro at
physiological NAD+ levels, we assayed product formation at increasing concentrations of
NAD+ substrate that include higher, more physiological concentrations of NAD+
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(Supplementary Fig. 7b). This analysis was done in the absence of DNA since our initial
results indicated that the lower activity of the both PARP1 and PARP1D-loop Pro highlighted
the difference in the pattern of incorporation. At all NAD+ concentrations PARP1D-loop Pro
reactions were enriched for PAR resolving at higher MW relative to wild type, confirming
that this enrichment is due to the inherent enzymatic activity of the PARP1D-loop Pro
(Supplementary Fig. 7b).
Two possibilities could result in the higher MW PAR found in the PARP1D-loop Pro: an
increase in branching, which has been suggested to contribute to high molecular weight
PAR41, and the synthesis of longer polymer. To test for differences in the levels of
branching, we treated automodified wild type and PARP1D-loop Pro with phosphodiesterase I
and analyzed the released products via 2D-TLC (Supplementary Fig. 7c). The (PR)2AMP to
PRAMP signal ratio found in wild type and PARP1D-loop Pro were similar, suggesting that
there was no difference in branching between the two products.
To test for differences in polymer length, PAR synthesized by wild type PARP1 and
PARP1D-loop Pro was analyzed by resolving CHES and NaOH released product on TBE
sequencing gels (Fig. 7d). CHES release was incomplete, with the unreleased product for the
PARP1D-loop Pro samples highly enriched for high molecular weight PAR (Supplementary
Fig. 7d). PAR released from PARP1D-loop Pro reactions exhibited a higher molecular weight
distribution relative to wild type for both CHES and NaOH as analyzed by TBE gel analysis
suggesting that they contained longer polymers (Fig. 7d). To better understand the reaction
product generated by PARP1 and PARP1D-loop Pro, kinetic analysis was performed (Fig. 7e).
Wild type PARP1 and PARP1D-loop Pro incorporated NAD+ with similar kinetics at early
time points (1-5 minutes), however at later time points (including 30 min. when samples
shown on Fig. 7d were obtained) when the incorporation kinetics of PARP1 plateaued,
PARP1D-loop Pro incorporation continued to increase, consistent with the hypothesis that the
higher molecular weight product results from generation of longer PAR polymers (Fig. 7e).
Amino acid specificity of PARP ADP-ribosylation reactions
PARP1 has been shown to modify acidic residues and lysines34-39. Because differences in
the structures of the acceptor pockets or other structural or enzymatic differences that exist
between MAR versus PAR generating PARPs could impact which amino acids are targeted
for modification, we determined if MAR generating PARPs exhibit similar a.a. target
selectivity. To do so we examined PARP3, 6, 9, 10, 11, 12, and 16 automodification
reactions using mass spectrometry (Table 2 and Supplementary Table 2). PARP3 was
specifically examined since it contains H-Y-E but only makes MAR. Our data identify
glutamate and aspartate residues as the most commonly targeted amino acids for
modification, especially for PARP3. Many preparations also contained modifications on
lysine (Table 2) consistent with previously published results for PARP1, although we cannot
rule out the possibility that non-enzymatic chemical ligation is responsible for modifications
at these sites, a known phenomenon62.
Surprisingly, we also identified ADP-ribosylated cysteines in PARP 6, 8, 11 and 12 samples.
Interestingly, although multiple clustered ADP-ribosylated cysteine residues were identified
in PARP8, no modifications of acidic residues or lysines were detected, although this does
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not imply that they are not present. Furthermore, these modifications occurred in the
PARP6/8-specific cysteine rich domain that precedes the catalytic domain. Altogether, these
observations may suggest that cysteine could be modified by some of the MAR generating
PARPs. However, as cysteine modifications were identified prior to addition of exogenous
NAD+, it is also possible that MAR-cysteine modification is due to the activity of other
enzymes present in the human cell extracts (Supplementary Table 2).
To determine if the cysteine modifications were dependent on PARP activity, all four
cysteines identified as ADP-ribosylated in PARP8 were mutated to alanines and
automodification reactions were performed for wild type and cysteine mutant GFP-PARP8
(Supplementary Fig. 8a). A ~10-20% decrease in the amount of NAD+ incorporated was
identified for the cysteine mutant depending on the concentration of NAD+ tested,
suggesting that they are genuine sites of PARP8 automodification (Supplementary Fig. 8a).
Additional unidentified modification sites are present in PARP8 as NAD+ incorporation
signal remained in the mutant (Supplementary Fig. 8a). NAD+ incorporation was not
observed using a catalytic dead point mutant of PARP8 (PARP8H697A), suggesting that the
cysteine modifications are dependent on catalytic activity and are not due to non-enzymatic
chemical ligation (Supplementary Fig. 8b).
A large number of modification sites, mainly in PARP10 samples, occurred on the N-
terminus of peptides suggesting that they could be experimental artifact (Supplementary
Table 3). Although all the ADP-ribosylation peptides reported here have been identified
very confidently, we are less confident about the precise localization of ADPr modifications
at the sites reported in grey in Table 2 (the peptide N-terminus of these peptides might be
modified instead of the side chain of the internal residue) and they are therefore shown
provisionally. In addition to cysteine, we detected ADP-ribosylation of three arginine
residues on PARP10 (Supplementary Table 3). As all three ADP-ribosylated arginines are
the first residues of the peptide, the modification could occur either on the guanidine group
(arginine side chain) or on the amino group (peptide N-terminus).
No sites were identified for PARP9 protein consistent with the known lack of catalytic
activity of this protein.
Discussion
To systematically identify the enzymatic activity of each PARP protein, we performed
multiple assays to accurately identify the reaction products for the entire family. Our data
indicate that the major activity for most of the PARPs is mono(ADP-ribosyl)ation. We can
now confidently ascribe MAR activity to the newly identified functions for PARPs in actin
cytoskeletal regulation, membrane organelle regulation, signal transduction, the unfolded
protein response, and the cytoplasmic stress response. This suggests that the mechanisms of
PARP functions in these pathways are mediated by MAR modifications of target proteins,
unless these PARPs function in an ADPr synthesis independent manner.
Although the use of recombinant protein is standard in the PARP field, it is important to
note that the use of recombinant proteins expressed as GFP-fusion proteins has potential
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limitations compared to analysis of endogenous protein. For instance, although the GFP tag
had no effect on the enzymatic activity of PARP1 or PARP10 (Supplementary Fig. 1), we
cannot completely rule out the possibility that it does not affect the activity of other PARPs.
However this systematic analysis would not have been possible without the use of
recombinant protein as it enabled purification of large amounts of pure protein necessary for
such analysis. Studies of MARylating PARPs have shown that trans substrates are also
MAR-modified suggesting that automodification is a useful assay of activity26,47, however it
is possible that some PARPs may have substrate specific enzymatic activity not detected
using automodification. Identifying the protein targets of MAR activity and identifying
mechanisms of MAR function will be critical.
The MAR activity exhibited by PARP3 and 4, coupled with the analysis of the PARP1/
PARP3 and PARP1/PARP16 chimeras demonstrate the importance of the D-loop in the
function of the catalytic domain. Its importance is further illustrated by the ability of the
PARP1 D-loop chimera to restore PARP16Y254E synthesis activity, suggesting that D-loop
function can overcome deficiencies of H-Y-E motif mutants. The proline residues of the
PARP1 D-loop have been proposed to provide structural rigidity30 but the requirement for
this rigidity in enzymatic activity had not been investigated. The mutation of the D-loop
prolines to alanines resulted in an enzyme that generates longer polymer and has increased
enzyme kinetics. This increase in polymer length produced by PARP1D-loop Pro could be due
to several factors including decreased self-regulation- automodification normally
downregulates PARP1 enzymatic activity and this mechanism of self-regulation could be
deficient in the PARP1D-loop Pro mutant. Another possibility is an increase in the
processivity of the enzyme since communication between the D-loop and the A-loop is
possible. Regardless, our results suggest that the D-loop confers important regulatory
information to the catalytic domain. Our results also suggest that the acceptor loop is
important for the enzymatic activity of PARPs, but not the type of modification generated,
since the PARP1P16 A-loop chimera continued to generate PAR, albeit at lower levels. This is
consistent with a function for the A-loop in the binding to substrate, either elongating
polymer, or protein target.
Consistent with results for PARP1, both acidic residues and lysines were identified as
targets of MAR generating PARPs suggesting that, in general, MAR and PAR generating
PARPs modify similar amino acids. These results also argue that the sequence and structural
constraints limiting PARPs to MAR synthesis, including the H-Y-E containing PARP3, do
not affect their ability to modify canonical amino acid targets. In contrast our identification
of cysteine modifications suggest that MARylating PARPs may have the ability to modify a
larger diversity of amino acids although it remains to be determined if PARylating PARPs
can also generate cysteine modifications.
Why do cells need both types of ADPr modifications? MAR and PAR synthesis activities
are both evolutionarily conserved, indicating that both have important functions in cellular
physiology63. PAR functions during stress responses and physiological pathways that
require the rapid assembly of multiprotein complexes, acting as a protein binding scaffold.
The consequences of MAR modifications on target protein are less understood. Recent work
showing that ADPr-binding Macro domain-containing proteins can specifically bind
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MARylated targets suggests that one function could be to regulate specific protein-protein
interactions, similar to SH2 domains binding to phosphoproteins17,23,64. MAR modifications
are also especially interesting because they could serve as primers for further elongation to
PAR, with PARPs functioning cooperatively to synthesize polymer, allowing a cell to
tightly regulate each step of PAR generation. This possibility is supported by in vitro data
showing heterodimerization and activation of PARPs with distinct activities, by the fact that
PARPs with each activity are localized in both the cytoplasm and nucleus and by the
presence of multiple physiological protein complexes containing MAR and PAR generating
PARPs13,27,45,58,65. A closer examination of MAR function, and a closer examination of the
ability of MAR to initiate PAR polymerization will be important.
Methods
Cell culture and reagents
293F cells (from ATCC) were grown at 37°/5% CO2 in F17 media supplemented with 2%
glutamax (Life Technologies). 32P-NAD+ was from Perkin Elmer. Bovine PARG and 10×
Activated DNA was from Trevigen.
NAD+ Incorporation Reaction
GFP-PARPs or SBP-PARPs were expressed in 293F cells. 24-48hrs after transfection, cells
were washed 3× in ice-cold PBS and lysed for 20min on ice in cell lysis buffer (CLB, 50mM
HEPES, pH7.4, 150mM NaCl, 1mM MgCl2, 1mM EGTA, 1mM DTT, 1% Triton-X 100, 1
μg/mL leupeptin, aprotinin, pepstatin, PMSF). Lysates were subject to ultracentrifugation at
100K*g for 30min. Cleared lysates were incubated for 1hr at 4°C either with anti-GFP
antibody (3E6, Life Technologies) pre-bound protein A magnetic beads (Millipore) or
streptavidin sepharose (GE Healthcare Life Sciences). Beads were than washed 1×5min in
CLB, followed by 3×10min washes in CLB containing 1M NaCl, and 1×5min wash in
PARP reaction buffer (PRB; 50mM Tris, pH7.5, 50mM NaCl, 0.5mM DTT, 0.1% Triton-X
100, 1 μg/mL leupeptin, aprotinin, pepstatin). Soluble PARP10 was produced by cleaving
the SBP tag from immunoprecipitated SBP-PARP10 at Prescission protease sequence using
HRV3C (Sigma-Aldrich).
NAD+ incorporation reactions were performed in PRB containing 10μM NAD+ (unless
otherwise indicated) supplemented with 32P-NAD at a 1:20 ratio for 30min at 25°C. For
PARPs with low incorporation signals (PARP4, 5a and 16), NAD+ incorporation was
performed using a 1:5 ratio for 1hr at 25°C for TLC and sequencing gel analysis of released
products. For PARPs 1-3, activated DNA was added to NAD+ incorporation reaction for
TLC and sequencing gel analysis of released products. Following NAD+ incorporation,
beads were washed 6×5min in PRB supplemented with 1M NaCl, 100μM NAD+ and 10μM
ATP and 2×5min in PRB containing 100μM NAD+ and 10μM ATP. Beads were then
resuspended in Laemmli sample buffer, heated to 65°C for 10 minutes and run on 8% SDS-
PAGE gels followed by autoradiography.
For enzymatic and chemical treatments, beads were treated with indicated enzyme or
chemical following NAD+ incorporation and washes. MacroD1 was used at 0.5μM and T.c.
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PARG was used at 0.1μM for 1 hour at 25°C. CHES release was performed for 2 hours at
37°C. Beads were then resuspended in Laemmli sample buffer and reaction supernatants
were collected and either spotted on PEI-cellulose thin layer chromatography plates
(Macheray-Nagel) and resolved in 0.15M LiCl/0.15M formic acid or diluted 1:1 in PAR
loading buffer (50% urea, 25mM NaCl, 2mM EDTA, 0.1% xylene cyanol, 0.1%
bromophenol blue) and resolved on 20% polyacrylamide-TBE sequencing gels.
For analysis of PARP1D-loop Pro, NAD+ titration was performed using a ratio of 0.75μCi hot
NAD+:10μM cold NAD+. For kinetic analysis, reactions were stopped using 20% TCA at
indicated time points, incubated on ice for a minimum of 30 minutes, and spun at 16.1K*g
for 30 minutes at 4°C. TCA pellets were washed with 5% TCA 3 times and treated with
0.5mL 0.1N NaOH, 2% SDS at 37°C overnight. Resuspended pellets were transferred to
scintillation vials containing 5mL of Emulsifier-Safe scintillation fluid (Perkin Elmer) and
analyzed by liquid scintillation counting. High pH release of PAR chains was performed in
0.1N NaOH, 20mM EDTA at 60°C for 2 hours. Samples were neutralized with 0.1N HCl
and analyzed by sequencing gels as described.
PARP Chimera Generation
Geneart strings (Life Technologies) or G-blocks (IDT) were generated in which either the
donor and acceptor loops of PARP’s 1, 3 and 16 were switched. See Supplementary
Methods for amino acid sequences that were switched. EcoRV (internal site)/SalI were used
to clone PARP1 fragments into PARP1/eGFPC1, SbfI (internal site)/SalI were used to clone
PARP3 fragments into PARP3/eGFPC1, and PstI (internal site)/SalI were used to clone
PARP16 fragments into PARP16/eGFPC1. Constructs were expressed in 293F cells and
used for NAD+ incorporation assays as described above.
Mass Spectrometry Analysis
Streptavidin binding peptide tagged-PARP6, 8, 9, 10, 11 and 12 fusions were expressed in
293F cells and immunoprecipitated as described above. Following 3×10 minute washes in
1M NaCl/CLB, streptavidin sepharose beads were washed 2×5 minutes in PRB and proteins
were eluted in 4mM biotin/PRB for 1 hour at 25°C. PARP16 (1-273 AA) and PARP3 were
purified with N-terminal His-tags in from E. coli as previously described66.
PARPs were incubated with 0.2mM NAD+ and ADP-ribosylated PARPs were digested with
trypsin by using a modified FASP protocol67. The samples were solubilized in 8 M urea 100
mM Tris pH 8 and loaded on a centrifugal filter (Vivacon 500, 50 kDa MW cutoff, Sartorius
Stedim Biotech). The low-molecular-weight components were removed by washing four
times with 8 M urea. Urea was removed by washing four times with 100 mM ammonium
bicarbonate and proteins were digested with trypsin (trypsin Gold, Promega, Madison,
USA). Following overnight digestion, the resulting peptides were eluted from the filter by
centrifugation and further recovered with two additional washes using 100 mM ammonium
bicarbonate. The eluted peptides were dried in a vacuum centrifuge system (Vacufuge,
Eppendorf, Hamburg, Germany) and resuspended in 40 μl 1% formic acid. The acidified
peptide mixtures were analyzed by nanoflow LC-MS/MS using a Q Exactive hybrid
quadrupole-Orbitrap mass spectrometer (Thermo Scientific, Bremen, Germany). Following
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separation on a Thermo Scientific EASY-Spray PepMap C18 column (75 μm inner diameter
× 50 cm, 2 μm particle size, 100 Å pore size) using an EASY-nLC 1000 UPLC system
(Thermo Scientific, Odense, Denmark), peptides were injected into the mass spectrometer
through a Thermo Scientific EASY-Spray ion source. Optimal loading amounts were
experimentally determined by injecting 1 μl (1/40) of the sample using a 90-minutes
gradient (linear gradient from 0 to 22 % acetonitrile for 60 minutes) and the samples were
sequentially analyzed multiple times using 150-minutes gradients (linear gradient from 0 to
22 % acetonitrile for 120 minutes) and different mass spectrometric acquisition parameters
(see below) to maximize the quality of MS/MS spectra. The Q Exactive was operated in the
data dependent mode to automatically switch between MS and MS/MS acquisition with the
following general parameters: survey full MS spectra acquired with a m/z range of 300-1800
Th, the resolution set to as value of 70 000 and AGC (automatic gain control) target value of
1 000 000 ions; dynamic exclusion of 40 seconds. In the “standard” acquisition method up
to 10 most intense ions were fragmented by higher-energy collisional dissociation (HCD)
with a maximum injection time of 60 ms, resolution of 17 500 and target value of 1 000 000.
Additionally, the samples were analyzed by two highly sensitive acquisition methods both
with a maximum injection time of 1 000 ms and resolution of 35 000. In the first highly
sensitive method up to 5 most intense ions were fragmented and scanned with the target
value of 500 000; for the second highly sensitive method the most intense precursor ion was
sequenced with the target value of 1 000 000.
Raw data were combined and analyzed with Andromeda-based MaxQuant (version
1.3.0.5)68. The search was performed the against UniProtKB human proteome (canonical
and isoform sequences; downloaded in April 2013;). Enzyme specificity was set to trypsin
allowing for up to four missed cleavages. Methionine oxidation, protein N-acetylation and
ADP-ribosylation (mass shift of 541.0611) on glutamate, aspartate, cysteine, arginine, lysine
and on the peptide N-terminus were set as variable modifications. MaxQuant was set up to
automatically search for the following diagnostic ions in MS/MS spectra matched to ADP-
ribosylated peptides: adenine (mass 135.0545), adenosine –H2O (mass 249.0862), adenosine
monophosphate (AMP; mass 347.0631), adenosine diphosphate (ADP)69. All reported
fragmentation spectra were manually validated using stringent criteria (supplementary
MS/MS spectra).
Raw data (mzML format) and manually annotated spectra have been submitted to Peptide
Atlas (http://www.peptideatlas.org/), where they are available under the identifier
PASS00485.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. H-Y-E motif is not the sole indicator for PAR synthesis activity
GFP-PARPs were immunoprecipitated from 293F cells and subjected to NAD+
incorporation reactions in vitro with 5 or 10μM cold NAD+ supplemented with a constant
ratio of 32P-NAD+. Automodifed PARPs were resolved on SDS-PAGE gels and subjected to
autoradiography. Representative coomassie stained gels for each PARP purification are
shown to the left of the autoradiogram and the expected molecular weight of the PARP
indicated by an asterisk. Assays were repeated at least twice. Of the H-Y-E motif containing
PARPs, PARP1, 2, 5a and 5b generated polymer, as evidenced by the smear of signal
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starting from the molecular weight of the PARP. The remaining PARPs resolve as a discreet
band, indicating that they do not generate poly(ADP-ribose). See also Supplementary Fig.
1-3.
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Figure 2. Enzymatic and chemical release of H-Y-E PARPs indicates that additional features of
PARP catalytic domain impact to enzymatic activity
Automodified PARPs were treated with CHES or the indicated wild type and catalytically
inactive ADPr hydrolytic enzyme. Signal remaining attached to protein was analyzed by
SDS-PAGE (top row), coomassies of either IgG (PARPs 1, 2, 5a and 5b) or PARP (PARP3
and 4) are shown below. Released product was analyzed by TLC (middle row) and
sequencing gel (bottom row). Assays were repeated at least twice. PARPs 1, 2, 5a and 5b
release PAR ladders upon CHES treatment and are sensitive to T.c. PARG hydrolysis. In
contrast, PARP3 and 4 release ADPr upon CHES, MacroD1 and T.c. PARG treatment,
indicative of MAR synthesis activity. See also Supplementary Fig. 4-7.
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Figure 3. Enzymatic and chemical release shows that MAR synthesis is the primary activity of
non-H-Y-E PARPs
Automodified PARPs were treated with CHES or the indicated wild type and catalytically
inactive ADPr hydrolytic enzyme. Signal remaining attached to protein was analyzed by
SDS-PAGE (top row), coomassies for each PARP are shown below. Released product was
analyzed by TLC (middle row) and sequencing gel (bottom row). Assays were repeated at
least twice. CHES, MacroD1 and T.c. PARG treatment of non-H-Y-E PARPS results in
ADPr release, indicative of MAR synthesis activity. See also Supplementary Fig. 4, 5 and 8.
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Figure 4. Comparison of chemical treatments to release ADPr linkages
Automodified PARP1, 7, 10 and 11 were treated with 100mM CHES, pH9, 2mM EDTA or
0.4M Hydroxylamine, pH 7.5, 2mM EDTA or 100mM Tris, pH12, 1mM EDTA. Released
products were analyzed both on 20% TBE-polyacrylamide sequencing gels (left) and TLC
(right). Hydroxylamine treatment does not release PAR ladders from PARP1 and high pH
treatment results in the degradation of ADPr to AMP.
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Figure 5. DNA dependence of PARP enzymatic activity
GFP-PARPs 1, 2, 3 and 10 were immunoprecipitated from 293F cells and subjected to
NAD+ incorporation reactions in vitro with 10μM cold NAD+ supplemented with a constant
ratio of 32P-NAD+, with or without the addition of activated DNA. Automodified PARPs
were resolved on SDS-PAGE gels and subjected to coomassie staining and autoradiography.
Addition of DNA to PARPs 1, 2, and 3 results in upregulation of enzymatic activity whereas
PARP10 activity is slightly decreased.
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Figure 6. Bovine PARG treatment of poly and mono(ADP-ribosyl)ating PARPs
Automodified GFP-PARPs 1, 3, 4 and 10 were treated with a titration of bovine PARG
ranging from 1-10ng/mL. GFP-PARP1, which produces PAR, is sensitive to bovine PARG
treatment whereas GFP-PARPs 3, 4 and 10, which produce MAR, do not show any decrease
in signal upon bovine PARG treatment. Assay was repeated twice.
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Figure 7. Impact of donor and acceptor loops on enzymatic activity
a) Wild type and chimeric GFP-PARP1 and 16 constructs were expressed in 293F cells,
immunoprecipitated and subject to in vitro NAD+ incorporation assays. Assays were
repeated twice. Replacement of PARP1 donor loop with PARP16’s (PARP1P16 D-loop)
inhibited PAR synthesis activity instead resulting in MAR synthesis. In contrast replacement
with the acceptor loop of PARP16 (PARP1P16 A-loop) retained PAR synthesis, but decreased
total PAR activity. PARP16 activity was unchanged after replacement with either the
PARP1 donor or acceptor loop. In contrast, PARP16Y254E inhibits the endogenous MAR
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synthesis activity that is restored by replacement with either the donor or acceptor loops of
PARP1. b, c) Wild type, PARP1D-loop Pro and chimeric GFP-PARP1 and 3 constructs were
expressed in 293F cells, immunoprecipitated and subject to in vitro NAD+ incorporation
assays either with (b) or without (c) DNA. Assays were repeated twice. Mutation of the 3
proline residues in the PARP1 D-loop results in an enrichment for PAR that resolves higher
on the SDS-PAGE gel whereas replacement with the PARP-3 donor loop results in MAR
synthesis activity in the absence and presence of DNA. The GFP-PARP3P1 D-loop construct
is not active. d) Wild type GFP-PARP1 and GFP-PARP1D-loop Pro were automodified and
attached PAR chains were released with either CHES or NaOH and analyzed by sequencing
gel. Assay was repeated twice. GFP-PARP1D-loop Pro is enriched for longer polymer. e)
NAD+ incorporation kinetics of wild type GFP-PARP1 and GFP-PARP1D-loop Pro indicate
that, although both proteins have similar initial reaction rates, the PARP1D-loop Pro
incorporation reaction does not plateau with similar kinetics, n≥3, error bars represent
standard deviation, data fit to logarithmic regression. Representative coomassie stain of
input shown to right. See also Supplementary Figures 6 and 7.
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Table 1
Summary of PARP enzymatic activity
Activity PARP Other Names Catalyt ic Motif
PAR
1 PARPARTD1 H-Y-E
2 ARTD2 H-Y-E
5a TNKS1ARTD5 H-Y-E
5b TNKS2ARTD6 H-Y-E
MAR
3 ARTD3 H-Y-E
4 vPARPARTD4 H-Y-E
6 ARTD17 H-Y-I
7 tiPARPARTD14 H-Y-I
8 ARTD16 H-Y-I
10 ARTD10 H-Y-I
11 ARTD11 H-Y-I
12 ARTD12 H-Y-I
14 BAL2ARTD8 H-Y-L
15 BAL3ARTD7 H-Y-L
16 ARTD15 H-Y-Y
Inactive
9 BAL1ARTD9 Q-Y-T
13 ZC3HAV1ARTD13 Y-Y-V
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Table 2
ADP-ribosylation sites identified by mass spectrometry analysis of automodified PARPs
For the peptides highlighted in grey the MS/MS spectra do not contain enough information to distinguish
between ADP-ribosylation on the internal residue from the modification on the peptide N-terminus
Protein Amino acid Position Peptide sequence
PARP3 (540 aa)
Glu 19 _PKPWVQTE(ad)GPEK_
Glu 22 _PKPWVQTEGPE(ad)K_
Glu 33 _QAGREE(ad)DPFR_
Glu 41 _STAE(ad)ALK_
Glu 170 _YTLIEVQAEDEAQE(ad)AVVK_
Glu 238 _GFE(ad)ALEALEEALK_
Glu 316 _TVE(ad)EVPHPLDR_
Glu 317 _TVEE(ad)VPHPLDR_
Glu 351 _VIQTYLE(ad)QTGSNHR_
Glu 456 _E(ad)HHINTDNPSLK_
Asp 148 _D(ad)HFVSHPGK_
Asp 217 _NTMALMD(ad)LDVK_
Lys 13 _PK(ad)PWVQTEGPEK_
Lys 44 _STAEALK(ad)AIPAEK_
PARP6 (630 aa)
Asp 600 _FFFVYED(ad)GQVGDANINTQDPK_
Cys 237 _VEVFGYPPSPQAGLLC(ad)PQHVGLPPPAR_
PARP8 (854 aa)
Cys 332 _TDDVC(ad)VTK_
Cys 367 _LLNRPC(ad)PAAVK_
Cys 376 _SEEC(ad)LTLK_
Cys 395 _C(ad)EHNTNLKPHK_
PARP10 (1025 aa)
Glu 106 _LE(ad)QHVQALLR_
Lys 140 _ALVQLPK(ad)PLSEADVR_
Lys 916 _NATVYGK(ad)_
PARP11 (331 aa)
Glu 6 _AE(ad)ELFSK_
Asp 80 _ID(ad)FAEMK_
Cys 49 _WHMFQPDTNSQC(ad)SVSSEDIEK_
Cys 65 _TNPC(ad)GSISFTTSK_
Lys 11 _AEELFSK(ad)_
PARP12 (701 aa)
Asp 600 _D(ad)AAYSHHYSK_
Asp 611 _SD(ad)TQTHTMFLAR_
Cys 474 _YVSPQDVTTMQTC(ad)NTK_
Cys 584 _VC(ad)GVHGTSYGK_
PARP16 (322 aa)
Glu 77 _E(ad)LLQSSGDNHKR_
Asp 37 _D(ad)SVLRPFPASYAR_
Lys 110 _IQK(ad)LTGAPHTPVPAPDFLFEIEYFDPANAK
Lys 137 _LTGAPHTPVPAPDFLFEIEYFDPANAK(ad)_
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